Cumulative Troponin T Release after Acute Myocardial Infarction. Influence of Reperfusion

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 6, 1997, Pages 459-468

  Kragten, Johannes A ^a   Hermens, Wim Th ^b   Dieijen Visser, Marja P van ^c  

^a Zuyderland Medical Centre   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; FIBRINOLYTIC AGENT; HEART ENZYME; HYDROXYBUTYRATE DEHYDROGENASE; TROPONIN T;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; CREATINE KINASE; FEMALE; HUMANS; HYDROXYBUTYRATE DEHYDROGENASE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TIME FACTORS; TROPONIN; TROPONIN T;

EID: 0030839039     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.6.459     Document Type: Article

References (41)

1. Kennedy J, Ritchie J, Davis K, Stadius M, Maynard C, Fritz J. The Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. New Engl J Med 1985: 312: 1073-8.
2. GISSI-1. (Gruppo Italiano per lo studio della streptochinasi neU'infarto miocardico) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986: i: 349-360.
3. Tiefenbrunn A, Sobel B. Thrombolysis and myocardial infarction. Fibrinolysis 1991: 5: 1-15.
4. Kircher B, Topol B, O'Neill W, Pitt B. Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. Am J Coll Cardiol 1987: 59: 513-515.
5. Califf RM, O'Neill W, Stack RS, Aronson L, Mark DB, Mantell S, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988: 108: 658-662.
6. Katus H, Remppis A, Scheffold T, Diederich K, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991: 67: 1360-7.
7. Apple FS. Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990s. Am J Clin Pathol 1992: 97: 217-226.
8. Zabel M, Hohnloser SH, Koster W, Prinz M, Kasper W, Just H. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993: 87: 1542-50.
9. Mair J, Puschendorf B, Michel G. Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury. Adv Clin Chem 1994: 31: 63-98.
10. Abe S, Arima S, Yamashita T, Miyata M, Okino H, Toda H, et al. Early assessment of reperfusion therapy using cardiac troponin T. J Am Coll Cardiol 1994: 23: 1382-9.
11. Mair J, Wagner I, Jacob G, Lechleitner P, Dienstl F, Puschendorf B, et al. Different time courses of cardiac contractile proteins after acute myocardial infarction. Clin Chim Acta 1994: 231: 47-60.
12. Remppis A, Scheffold T, Karrer O, Zehelein J, Hamm C, Grunig E, et al. Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J 1994: 71: 242-248.
13. Lavin F, Kane M, Forde A, Gannon F, Daly K. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. Br Heart J 1995: 73: 422-427.
14. Laperche T, Steg PG, Dehoux M, Benessiano J, Grollier G, Aliot E, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. Circulation 1995: 92: 2079-86.
15. Apple FS, Voss E, Lund L, Preese L, Berger CR, Henry TD. Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy. Clin Chim Acta 1995: 237: 59-66.
16. Mair J, Artner-Dworzak E, Lechleitner P, Schmidt J, Wagner I, Dienstl F, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991: 37: 845-852.
17. Gerhardt W, Katus H, Ravkilde J, Hamm C, Jorgensen P, Peheim E, et al. Serum troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentration of serum creatine kinase isoenzyme MB. Clin Chem 1991: 37: 1405-11.
18. Remppis A, Scheffold T, Greten J, Haass M, Greten T, Kubler W, et al. Intracellular eompartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995: 27: 793-803.
19. Kragten J, Hermens W, Van Dieijen-Visser M. Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes. Ann Clin Biochem 1996: 33: 314-323.
20. Willems G, Visser M, Krill M, Hermens W. Quantitative analysis of plasma enzyme levels based on simultaneous determination of different enzymes. Cardiovasc Res 1982: 16: 120-131.
21. Hermens W, Van der Veen F, Willems G, Mullers-Bouman M, Schrijvers-van Schendel A, Reneman R. Complete recovery in plasma of enzymes lost from the heart after permanent coronary occlusion in the dog. Circulation 1990: 81: 649-659.
22. Katus H, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989: 21: 1349-53.
23. Visser M, Krill M, Willems G, Hermens W. Selection of a suitable model for the plasma clearance and distribution of cardiac enzymes in the dog. Cardiovasc Res 1981: 15: 35-42.
24. Van Kreel B, Van der Veen F, Willems G, Hermens W. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993: (Heart Circ Vol 33): H747-HH54.
25. Hermens W, Willems G, Visser M. quantification of circulating proteins. The Hague: Martinus Nijhoff Publishers, 1982.
26. Roberts R. Enzymatic estimation of infarct size. Thrombolysis induced its demise: will it now rekindle its renaissance? Circulation 1990: 81: 707-710.
27. Van der Veen F, Hermens W, Willems G, Schrijvers-van Schendel A, Mullers-Boumans M, Reneman R. Time course of cellular enzyme release in dog heart injury. Circ Res 1990: 67: 1257-66.
28. Kragten J, Van Nieuwenhoven F, Van Dieijen-Visser M, Theunissen P, Hermens W, Glatz J. Distribution of myoglobin and fatty acid binding protein in human cardiac autopsies. Clin Chem 1996: 42: 337-338.
29. Van der Laarse A, Kerkhof PLM, Serruys PW, Hermens WT, Verbeugt FWA, Bar FW, et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary or to conventional therapy. Am J Cardiol 1988: 61: 1-7.
30. Bahayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem 1995: 28: 1-19.
31. Burlina A, Zaninotto M, Secchiero S, Rubin D, Accorsi F. Troponin T as a marker of ischemic myocardial injury. Clin Biochem 1994: 27: 113-121.
32. Simoons M, Serruys P, van den Brand M, Res J, Verbeugt F, Krauss X, et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 1986: 7: 717-728.
33. De Zwaan C, Willems G, Vermeer F, Res J, Verbeugt f, Van der Laarse A, et al. Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction. Br Heart J 1988: 59: 175-183.
34. Anderson JL, Marshall HW, Askins JC, Lutz JR, Sorensen SG. A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation 1984: 70: 606-618.
35. Van de Werf F, Arnold A. For the European Cooperative Study Group for recombinant tissue type plasminogen activator: intravenous tissue plasminogen activator and size of infarct, left ventricular function and survival in acute myocardial infarction. Br Med J 1988: 297: 1374-9.
36. Clark G, Robinson A, Gnepp D, Roberts R, Sobel B. Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circ Res 1978: 43: 162-169.
37. Bleifeld W, Mathey D, Hanrath P, Buss H, Effert S. Infarct size estimated from serial creatine phosphokinase in relation to left ventricular dynamics. Circulation 1977: 55: 303-311.
38. Grande P, Hansen B, Christiansen C, Naestoft J. Estimation of acute myocardial infarct size in men by serum CK-MB measurements. Circulation 1982: 65: 756-764.
39. Hackel D, Reimer K, Ideker R, Mikat E, Hartwell T, Parker C, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation 1984: 70: 824-835.
40. Jansen DE, Corbett JR, Wolfe CL, Lewis SE, Gabliani G, Filipchuk N, et al. Quantification of myocardial infarction: a comparison of single photon-emission computed tomography with pyrophosphate to serial plasma MB-creatine kinase measurements. Circulation 1985: 72: 327-333.
41. Morrison J, Coromilas J, Munsey D, Robbins M, Zema M, Chiaramida S, et al. Correlation of radionuclide estimates of myocardial infarction size and release of creatine kinase-MB in man. Circulation 1980: 62: 277-287.